Jonathan Yao, MD

Xanthogranulomatous Reaction to Trametinib for Metastatic Malignant Melanoma

Publish date: October 2, 2018

Trametinib, a mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor, has demonstrated great promise in treating ...